ClavF derived from Clavanins as a promising candidate for fighting infections from multiple-drug resistance Aeromonas hydrophila
Fish & Shellfish Immunology · 2025
DOI: 10.1016/j.fsi.2025.110488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fish & Shellfish Immunology, 2025. Verfasst von Zhihao Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China. Hauptthemen laut MEDLINE: Fish Diseases, Gram-Negative Bacterial Infections, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, Scientific Research Foundation of Hunan Provincial Education Department, Scientific Research Fund of Hunan Provincial Education Department.
Abstract (Originalsprache)
The antimicrobial peptide ClavF was designed based on the natural antimicrobial peptide Clavanins, derived from the hemocytes of the stalked ascidian, using the amino acid substitution method. The antimicrobial activity of ClavF was tested against various multiple-drug resistance (MDR) pathogenic bacteria (Staphylococcus aureus, Aeromonas hydrophila, Escherichia coli and Salmonella pullorum), with minimal inhibitory concentrations (MICs) as low as 2 μM and the half-maximal inhibitory concentration (IC50) for Ctenopharyngodon idella kidney (CIK) cells is 50 μM. Its bactericidal mechanism against A. hydrophila primarily involves disrupting the bacterial cell membrane, leading to leakage of cellular contents. In the infected grass carps by MDR A. hydrophila, treatment with 100 μL of ClavF (200 μM) significantly increased the survival rate of infected fish, reduced spleen and intestinal damage, and effectively alleviated systemic inflammation caused by the infection. ClavF regulates the dynamic balance of inflammatory factors in key immune organs, such as the spleen and intestine, by significantly inhibiting the overexpression of pro-inflammatory factors like IL-1β and TNF-α during the early stages of infection. These results indicate that ClavF exhibits antibacterial and anti-inflammatory properties, making it a potent lead molecule for enhancing the comprehensive prevention and control of bacterial diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China.
- College of Fisheries, Hunan Agricultural University, Changsha, China.
- The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, China.
- College of Fisheries, Hunan Agricultural University, Changsha, China. Electronic address: whq@hunau.net.
- School of Public Health & Laboratory Medicine, Hunan University of Medicine, Huaihua, China. Electronic address: zouzx@hnmu.edu.cn.
- College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China; Hunan Provincial Engineering Technology Research Center for Cell Mechanics and Function Analysis, Changsha, China. Electronic addr…
Förderung
- Hunan Provincial Natural Science Foundation
- Scientific Research Foundation of Hunan Provincial Education Department
- Scientific Research Fund of Hunan Provincial Education Department
- National Natural Science Foundation of China
Zitieren
APA
Peng, Z., Wei, C., Li, B., Chen, M., Wang, H., Zou, Z., & Chen, J. (2025). ClavF derived from Clavanins as a promising candidate for fighting infections from multiple-drug resistance Aeromonas hydrophila. Fish & Shellfish Immunology. https://doi.org/10.1016/j.fsi.2025.110488
Vancouver
Peng Z, Wei C, Li B, Chen M, Wang H, Zou Z, et al. ClavF derived from Clavanins as a promising candidate for fighting infections from multiple-drug resistance Aeromonas hydrophila. Fish & Shellfish Immunology. 2025. doi:10.1016/j.fsi.2025.110488
BibTeX
@article{Peng2025,
author = {Peng, Zhihao and Wei, Chao and Li, Bin and Chen, Minzhi and Wang, Hongquan and Zou, Zhaoxia and Chen, Jinjun},
title = {ClavF derived from Clavanins as a promising candidate for fighting infections from multiple-drug resistance Aeromonas hydrophila},
journal = {Fish & Shellfish Immunology},
year = {2025},
doi = {10.1016/j.fsi.2025.110488}
}
EUVIMED